Search research articles
Contact Us
Filters
Showing results (351-360 of 455) with videos related to
Page
of 46
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
Genome Biology and Evolution
|
October 19, 2018
Genome Sequence of the Wheat Stem Sawfly, Cephus cinctus, Representing an Early-Branching Lineage of the Hymenoptera, Illuminates Evolution of Hymenopteran Chemoreceptors
Hugh M Robertson, Robert M Waterhouse, Kimberly K O Walden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
The Lancet. Oncology
|
October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
The Journal of Applied Ecology
|
February 16, 2016
Integrating spatially explicit indices of abundance and habitat quality: an applied example for greater sage-grouse management
Peter S Coates, Michael L Casazza, Mark A Ricca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Jacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Breast Cancer Research : BCR
|
November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Ecology and Evolution
|
October 11, 2024
Linking resource selection to population performance spatially to identify species' habitat across broad scales: An example of greater sage-grouse in a distinct population segment
Megan C Milligan, Peter S Coates, Brianne E Brussee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
Otto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Page
of 46
Search research articles
Search
Showing results (351-360 of 455) with videos related to
Sort By:
Page
of 46
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
Genome Biology and Evolution
|
October 19, 2018
Genome Sequence of the Wheat Stem Sawfly, Cephus cinctus, Representing an Early-Branching Lineage of the Hymenoptera, Illuminates Evolution of Hymenopteran Chemoreceptors
Hugh M Robertson, Robert M Waterhouse, Kimberly K O Walden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
The Lancet. Oncology
|
October 25, 2011
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Meredith M Regan, Patrick Neven, Anita Giobbie-Hurder, et al.
The Journal of Applied Ecology
|
February 16, 2016
Integrating spatially explicit indices of abundance and habitat quality: an applied example for greater sage-grouse management
Peter S Coates, Michael L Casazza, Mark A Ricca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 25, 2016
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Jacquie H Chirgwin, Anita Giobbie-Hurder, Alan S Coates, et al.
Breast Cancer Research : BCR
|
November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
Alan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Ecology and Evolution
|
October 11, 2024
Linking resource selection to population performance spatially to identify species' habitat across broad scales: An example of greater sage-grouse in a distinct population segment
Megan C Milligan, Peter S Coates, Brianne E Brussee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2015
Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
Otto Metzger Filho, Anita Giobbie-Hurder, Elizabeth Mallon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Page
of 46